COMPARATIVE SAFETY OF GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONISTS (GLP-1-RAS) IN TYPE 2 DIABETES AND CHRONIC WEIGHT MANAGEMENT: A REAL-WORLD DATA STUDY

Descargar Publicación
The Endocannabinoid System in the Development and Treatment of Obesity: Searching for New Ideas Pharmacotherapy for Obesity: Recent Updates